• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病和慢性心力衰竭:危险的组合。

Peripheral arterial disease and chronic heart failure: a dangerous mix.

机构信息

Centre for Cardiovascular and Chronic Care, Faculty of Nursing, Midwifery and Health, University of Technology Sydney, PO BOX 123, Broadway, 235 Jones Street, Ultimo, Sydney, NSW 2007, Australia.

出版信息

Heart Fail Rev. 2013 Jul;18(4):457-64. doi: 10.1007/s10741-012-9331-1.

DOI:10.1007/s10741-012-9331-1
PMID:22723049
Abstract

Chronic heart failure (CHF) is associated with a high comorbidity burden, adverse impact on quality of life and high health care utilisation. Peripheral arterial disease (PAD) and CHF share many risk, pathophysiological and prognostic features, and each has been associated with increased morbidity and mortality. PAD often goes undetected, and yet in spite of the availability of screening tools, this is not commonly considered in CHF care. A review of the electronic databases Medline, CINAHL and Cochrane CENTRAL was undertaken using the MeSH terms peripheral arterial disease, peripheral vascular disease, intermittent claudication and heart failure to identify studies examining the prevalence and clinical outcomes of coexisting PAD in patients with CHF. Five studies were identified. There are limited data describing the impact of PAD on CHF outcomes. As PAD may contribute to decreased capacity to exercise and other self-care behaviours, identifying those at risk and providing appropriate therapy are important. Based on this review, patients who are smokers and those with diagnosed coronary heart disease and diabetes should be targeted for the screening of PAD.

摘要

慢性心力衰竭(CHF)与高合并症负担、生活质量下降和高医疗保健利用率相关。外周动脉疾病(PAD)和 CHF 具有许多共同的风险、病理生理和预后特征,并且两者都与发病率和死亡率增加相关。PAD 常常未被发现,尽管有筛查工具,但在 CHF 护理中通常不考虑这一点。使用 MeSH 术语外周动脉疾病、周围血管疾病、间歇性跛行和心力衰竭,对 Medline、CINAHL 和 Cochrane CENTRAL 电子数据库进行了审查,以确定检查 CHF 患者并存 PAD 的患病率和临床结局的研究。确定了五项研究。描述 PAD 对 CHF 结局影响的数据有限。由于 PAD 可能导致运动能力下降和其他自我护理行为减少,因此识别高危人群并提供适当的治疗非常重要。基于这篇综述,应针对吸烟者以及诊断为冠心病和糖尿病的患者进行 PAD 筛查。

相似文献

1
Peripheral arterial disease and chronic heart failure: a dangerous mix.外周动脉疾病和慢性心力衰竭:危险的组合。
Heart Fail Rev. 2013 Jul;18(4):457-64. doi: 10.1007/s10741-012-9331-1.
2
The impact of peripheral arterial disease on patients with congestive heart failure.外周动脉疾病对充血性心力衰竭患者的影响。
Heart Fail Clin. 2014 Apr;10(2):327-38. doi: 10.1016/j.hfc.2013.10.006.
3
The Prognostic Value of Peripheral Artery Disease in Heart Failure: Insights from a Meta-analysis.
Heart Lung Circ. 2016 Dec;25(12):1195-1202. doi: 10.1016/j.hlc.2016.04.002. Epub 2016 Apr 26.
4
The effect of congestive heart failure on perioperative outcomes in patients undergoing lower extremity revascularization.充血性心力衰竭对接受下肢血管重建术患者围手术期结局的影响。
J Vasc Surg. 2016 May;63(5):1289-95. doi: 10.1016/j.jvs.2015.11.039.
5
Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease.心力衰竭与有症状外周动脉疾病的血管内介入治疗后的血管再通率降低有关。
J Vasc Surg. 2012 Feb;55(2):353-62. doi: 10.1016/j.jvs.2011.08.016. Epub 2011 Nov 1.
6
Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者的外周动脉疾病及不良结局风险
Clin Cardiol. 2017 Sep;40(9):692-696. doi: 10.1002/clc.22716. Epub 2017 Apr 26.
7
Impact of peripheral artery disease on prognosis in hospitalized heart failure patients.外周动脉疾病对住院心力衰竭患者预后的影响。
Circ J. 2015;79(4):785-93. doi: 10.1253/circj.CJ-14-1280. Epub 2015 Jan 28.
8
Impact of peripheral arterial disease on health status: a comparison with chronic heart failure.外周动脉疾病对健康状况的影响:与慢性心力衰竭的比较。
J Vasc Surg. 2009 Dec;50(6):1391-8. doi: 10.1016/j.jvs.2009.07.109.
9
Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.外周动脉疾病与心房颤动及中风、心力衰竭住院和心血管死亡风险:一项全国性队列研究。
Int J Cardiol. 2016 Jan 15;203:204-11. doi: 10.1016/j.ijcard.2015.10.091. Epub 2015 Oct 17.
10
[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].[重度外周动脉疾病患者慢性阻塞性肺疾病的诊断患病率及困难]
Pol Merkur Lekarski. 2009 Aug;27(158):92-6.

引用本文的文献

1
Effects of SGLT2 Inhibitors on Cardiovascular and Lower Limb Events in Patients with Type 2 Diabetes: A Nationwide Population-Based Study.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者心血管及下肢事件的影响:一项基于全国人群的研究
Diabetes Metab Syndr Obes. 2025 Mar 28;18:917-929. doi: 10.2147/DMSO.S515384. eCollection 2025.
2
Relationship between clinical congestion and worsening renal function after intravenous initiation of furosemide in patients with acute heart failure.急性心力衰竭患者静脉注射呋塞米后临床充血与肾功能恶化之间的关系。
Intern Emerg Med. 2025 Aug;20(5):1553-1564. doi: 10.1007/s11739-024-03796-0. Epub 2024 Oct 29.
3

本文引用的文献

1
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会外周动脉疾病患者管理指南重点更新(更新2005年指南):美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2011 Nov 1;58(19):2020-45. doi: 10.1016/j.jacc.2011.08.023. Epub 2011 Oct 6.
2
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).欧洲心脏病学会(ESC)外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜动脉、肾动脉、上肢和下肢动脉粥样硬化疾病的文件:欧洲心脏病学会外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2011 Nov;32(22):2851-906. doi: 10.1093/eurheartj/ehr211. Epub 2011 Aug 26.
Obese have comparable ankle brachial pressure index but higher β-cell function and insulin resistance as compared to normal-weight type 2 diabetes mellitus patients.
与正常体重的2型糖尿病患者相比,肥胖者的踝臂血压指数相当,但β细胞功能和胰岛素抵抗更高。
Acta Diabetol. 2025 Apr;62(4):543-550. doi: 10.1007/s00592-024-02379-x. Epub 2024 Oct 5.
4
The CorInnova Implantable Cardiac Assist System for Direct Cardiac Compression.用于直接心脏按压的CorInnova植入式心脏辅助系统。
Rev Cardiovasc Med. 2022 Jun 9;23(6):211. doi: 10.31083/j.rcm2306211. eCollection 2022 Jun.
5
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.心力衰竭、外周动脉疾病和达格列净:DAPA-HF 和 DELIVER 的患者水平荟萃分析。
Eur Heart J. 2023 Jun 25;44(24):2170-2183. doi: 10.1093/eurheartj/ehad276.
6
Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure.PARADIGM-HF 中得出的预后模型,并在 ATMOSPHERE 和瑞典心力衰竭注册中心中进行验证,以预测慢性心力衰竭的死亡率和发病率。
JAMA Cardiol. 2020 Apr 1;5(4):432-441. doi: 10.1001/jamacardio.2019.5850.
7
Diabetes and risk of peripheral artery disease in patients undergoing first-time coronary angiography between 2000 and 2012 - a nationwide study.2000 年至 2012 年间首次接受冠状动脉造影术的患者中糖尿病与外周动脉疾病风险的关系——一项全国性研究。
BMC Cardiovasc Disord. 2019 Oct 24;19(1):234. doi: 10.1186/s12872-019-1213-1.
8
Peripheral artery disease and outcomes in patients with acute myocardial infarction.外周动脉疾病与急性心肌梗死患者的预后
Open Heart. 2019 May 12;6(1):e001004. doi: 10.1136/openhrt-2018-001004. eCollection 2019.
9
Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease.近期心肌梗死后低步行障碍问卷评分可识别患有多血管疾病的患者。
JRSM Cardiovasc Dis. 2019 Apr 16;8:2048004019841971. doi: 10.1177/2048004019841971. eCollection 2019 Jan-Dec.
10
A New Clinically Applicable Measure of Functional Status in Patients With Heart Failure: The 60-Foot Walk Test.一种新的适用于心力衰竭患者功能状态的临床测量方法:60英尺步行测试。
JACC Heart Fail. 2017 Jun;5(6):411-420. doi: 10.1016/j.jchf.2017.02.005. Epub 2017 May 10.
3
Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review.心力衰竭方案的哪些组成部分有效?对 8323 例慢性心力衰竭管理中作为主要组成部分的结构化电话支持或远程监测的结局进行系统评价和荟萃分析:缩短版 Cochrane 综述。
Eur J Heart Fail. 2011 Sep;13(9):1028-40. doi: 10.1093/eurjhf/hfr039. Epub 2011 Jul 6.
4
Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management.老年心力衰竭患者的虚弱和多种合并症:对管理的影响。
Heart Fail Rev. 2012 Sep;17(4-5):581-8. doi: 10.1007/s10741-011-9258-y.
5
Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION).外周动脉疾病对心力衰竭患者功能和临床结局的影响(来自 HF-ACTION)。
Am J Cardiol. 2011 Aug 1;108(3):380-4. doi: 10.1016/j.amjcard.2011.03.057. Epub 2011 May 10.
6
What can we learn from patients with heart failure about exercise adherence? A systematic review of qualitative papers.我们能从心力衰竭患者身上学到什么关于运动依从性的知识?一项关于定性论文的系统综述。
Health Psychol. 2011 Jul;30(4):401-10. doi: 10.1037/a0022848.
7
The prevalence of asymptomatic and symptomatic peripheral arterial disease and peripheral arterial disease risk factors in the U.S. population.美国人群中无症状和有症状外周动脉疾病以及外周动脉疾病风险因素的患病率。
Holist Nurs Pract. 2011 May-Jun;25(3):147-61. doi: 10.1097/HNP.0b013e3182157c4a.
8
Arterial dysfunction and functional performance in patients with peripheral artery disease: a review.动脉功能障碍与外周动脉疾病患者的功能表现:综述。
Vasc Med. 2011 Jun;16(3):203-11. doi: 10.1177/1358863X11400935. Epub 2011 Mar 29.
9
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction.与射血分数降低的心衰相比,射血分数保留的心衰中合并症对功能损害的贡献更大。
Clin Res Cardiol. 2011 Sep;100(9):755-64. doi: 10.1007/s00392-011-0305-4. Epub 2011 Mar 17.
10
Ankle-brachial index improves the classification of cardiovascular risk: PERART/ARTPER Study.踝臂指数能改善心血管风险的分类:PERART/ARTPER 研究。
Rev Esp Cardiol. 2011 Mar;64(3):186-92. doi: 10.1016/j.recesp.2010.10.024. Epub 2011 Feb 16.